|
Transaction Size: |
SEK 56.7m |
|
Company Name: |
Bawat Water Technologies AB |
|
Closing: |
March 2022 |
|
Investor: |
Private and institutional investors |
|
TC Advisory: |
Translution Capital acted as exclusive financial advisor to Bawat Water Technologies AB in their IPO to private and institutional investors |
|
Transaction Size: |
NA |
|
Company Name: |
Moscord Pte.Ltd |
|
Closing: |
February 2022 |
|
Investor: |
Consortium of international institutional and strategic investors |
|
TC Advisory: |
Translution Capital acted as sole financial advisor to Moscord Pte.Ltd in securing their new funding round |
|
Transaction Size: |
NA |
|
Company Name: |
I Am Drinks ApS |
|
Closing: |
January 2022 |
|
Investor: |
REKOM Group A/S and Spritfabrikken Danmark ApS |
|
TC Advisory: |
Translution Capital acted as financial advisor to the selling shareholders of I Am Drinks ApS on the trade sale of the company |
|
Transaction Size: |
EUR 11m |
|
Company Name: |
Diok Real Estate AG |
|
Closing: |
December 2021 |
|
Investor: |
Collector Bank |
|
TC Advisory: |
Translution Capital acted as financial advisor to Diok Real Estate AG securing a funding package of EUR 11 million |
|
Transaction Size: |
SEK 509m |
|
Company Name: |
CombiGene AB |
|
Closing: |
November 2021 |
|
Investor: |
Spark Therapeutics, a company within the Roche Group |
|
TC Advisory: |
Translution Capital acted as financial advisor to CombiGene AB (publ.) in a deal securing a total funding package of up to SEK 509 million |
|
Transaction Size: |
SEK 44m |
|
Company Name: |
Expres2ion Biotech |
|
Closing: |
October 2021 |
|
Investor: |
Private and institutional investors |
|
TC Advisory: |
Translution Capital acted as financial advisor to Expres2ion Biotechnologies (publ.) in a new issue to private and institutional investors |
|
Transaction Size: |
Non-disclosed |
|
Company Name: |
CRisk Software ApS |
|
Closing: |
September 2021 |
|
Investor: |
Brady Technologies Limited, backed by private equity firm, Hanover Investors |
|
TC Advisory: |
Translution Capital acted as financial advisor to the selling shareholders of CRisk Software ApS on the trade sale of the company |
|
Transaction Size: |
SEK 308m |
|
Company Name: |
Allarity Therapeutics A/S |
|
Closing: |
August 2021 |
|
Investor: |
Broad range of investors |
|
TC Advisory: |
Translution Capital acted as financial advisor to Allarity Therapeutics A/S (Publ.) in a secured rights issue |
|
Transaction Size: |
SEK 150m |
|
Company Name: |
Biosergen AB |
|
Closing: |
June 2021 |
|
Investor: |
Private and institutional investors |
|
TC Advisory: |
Translution Capital acted as financial advisor to Biosergen AB in their IPO to private and institutional investors |
|
Transaction Size: |
Non-disclosed |
|
Company Name: |
Bawat A/S |
|
Closing: |
June 2021 |
|
Investor: |
Institutional and HNI investors |
|
TC Advisory: |
Translution Capital acted as sole financial advisor to Bawat A/S in relation to their fund raise led by selected institutional and HNI investors |
|
Transaction Size: |
SEK 39m |
|
Company Name: |
Expres2ion Biotech |
|
Closing: |
May 2021 |
|
Investor: |
Private and institutional investors |
|
TC Advisory: |
Translution Capital acted as financial advisor to Expres2ion Biotechnologies (publ.) in a new issue to private and institutional investors |
|
Transaction Size: |
DKK 180m |
|
Company Name: |
Medtrace Pharma A/S |
|
Closing: |
May 2021 |
|
Investor: |
ATP, BankInvest and Swisscanto |
|
TC Advisory: |
Translution Capital acted as financial advisor to Medtrace Pharma A/S in relation to their capital raise led by ATP, BankInvest and Swisscanto |
|
Transaction Size: |
Non-disclosed |
|
Company Name: |
Lamor Corporation AB |
|
Closing: |
April 2021 |
|
Investor: |
Institutional investors |
|
TC Advisory: |
Translution Capital acted as sole financial advisor to Lamor Corporation AB in relation to their fund raise led by selected institutional investors |
|
Transaction Size: |
DKK 150m |
|
Company Name: |
Plant Protein Venture |
|
Closing: |
March 2021 |
|
Lenders: |
Institutional investors |
|
TC Advisory: |
Translution Capital acted as financial advisor together with Nordic Investment Partners to secure total project financing |
|
Transaction Size: |
EUR 3m |
|
Company Name: |
Akvila Cutlery Oy |
|
Closing: |
February 2021 |
|
Lenders: |
Institutional investors |
|
TC Advisory: |
Translution Capital acted as sole financial advisor to Akvila Cutlery Oy in securing EUR 3m in debt financing |
|
Transaction Size: |
Non-disclosed |
|
Company Name: |
Bizbrains |
|
Closing: |
January 2021 |
|
Investor: |
VækstPartner Kapital |
|
TC Advisory: |
Translution Capital acted as sole financial advisor to Bizbrains in relation to the sale of a minority stake to VækstPartner Kapital |
|
Transaction Size: |
SEK 216m |
|
Company Name: |
Expres2ion Biotech |
|
Closing: |
November 2020 |
|
Investor: |
NYIP |
|
TC Advisory: |
Translution Capital acted as financial advisor to Expres2ion Biotechnologies (publ.) in a fully secured rights issue, with a directed issue to selected institutional investors |
|
Transaction Size: |
Non-disclosed |
|
Company Name: |
Sigma Estimates |
|
Closing: |
October 2020 |
|
Acquirer: |
EG A/S |
|
TC Advisory: |
Translution Capital acted as exclusive financial advisor to the owners of Sigma Estimates in relation to a trade sale of the company to EG |
|
Transaction Size: |
USD 182m |
|
Company Name: |
Margins Group |
|
Closing: |
August 2020 |
|
Investor: |
Institutional investors |
|
TC Advisory: |
Translution Capital acted as exclusive financial advisor to the owners of Margins Group on a USD 182m refinancing facility led by Institutional investors |
|
Transaction Size: |
DKK 10m |
|
Company Name: |
Scape Technologies |
|
Closing: |
May 2020 |
|
Investor: |
Institutional investors |
|
TC Advisory: |
Translution Capital advised the Danish manufacturer of industrial robots, Scape Technologies, securing a temporary loan facility |
|
Transaction Size: |
SEK 30m |
|
Company Name: |
Endomines |
|
Closing: |
April 2020 |
|
Lenders: |
Institutional investors & selected HNI’s |
|
TC Advisory: |
Translution Capital acted as financial advisor to Endomines in a short-term loan facility from Institutional investors and selected HNI’s |
|
Transaction Size: |
DKK 12m |
|
Company Name: |
FluoGuide |
|
Closing: |
January 2020 |
|
Investor: |
Institutional investors & selected HNI’s |
|
TC Advisory: |
Translution Capital acted as financial advisor to FluoGuide (Publ.) in a directed share issue to institutional investors and selected HNI’s |
|
Transaction Size: |
EUR 9.3m |
|
Company Name: |
Tamigo |
|
Closing: |
December 2019 |
|
Investor: |
Viking Ventures |
|
TC Advisory: |
Translution Capital acted as sole financial advisor to Tamigo in relation to the sale of minority stakes combined with a share issue to Viking Venture |
|
Transaction Size: |
SEK 7m |
|
Company Name: |
CombiGene |
|
Closing: |
November 2019 |
|
Investor: |
Institutional investors |
|
TC Advisory: |
Translution Capital acted as exclusive financial advisor to CombiGene, the listed Swedish gene therapy company in the bridge financing by Institutional investors |
|
Transaction Size: |
SEK 20m |
|
Company Name: |
CLS |
|
Closing: |
June 2019 |
|
Investor: |
Institutional investors |
|
TC Advisory: |
Translution Capital acted as exclusive financial advisor to CLS, the listed Swedish cancer ablation company in the bridge financing by Institutional investors |
|
Transaction Size: |
NOK 42m |
|
Company Name: |
5th Planet Games |
|
Closing: |
March 2019 |
|
Investor: |
Institutional investors |
|
TC Advisory: |
Translution Capital acted as sole financial advisor to 5th Planet Games in relation to the directed issue |
|
Transaction Size: |
SEK 36m |
|
Company Name: |
Expres2ion Biotech |
|
Closing: |
March 2019 |
|
Investor: |
Institutional investors |
|
TC Advisory: |
Translution Capital acted as exclusive financial advisor to Nasdaq First North company, Expres2ion Biotechnologies in the directed issue to Institutional investors |
|
Transaction Size: |
Non-disclosed |
|
Company Name: |
Conscia Danmark A/S |
|
Closing: |
March 2019 |
|
Acquirer: |
NA |
|
TC Advisory: |
Translution Capital acted as exclusive financial advisor to the owners of Conscia Danmark A/S in relation to a trade sale of the company |
|
Transaction Size: |
Non-disclosed |
|
Company Name: |
DCR Solutions |
|
Closing: |
December 2018 |
|
Investor: |
KMD Ventures and a consortium of Business Angels |
|
TC Advisory: |
Translution Capital acted as sole financial advisor to DCR Solutions in relation to the capital raise led by KMD Ventures and a consortium of Business Angels |
|
Transaction Size: |
USD 8.5m |
|
Company Name: |
Evaxion |
|
Closing: |
November 2018 |
|
Investor: |
Indonesian investor and 9 Danish Family Offices and Business angels |
|
TC Advisory: |
Translution Capital acted as sole advisor to Evaxion in relation to the capital raise led by an Indonesian investor and 9 Danish Family Offices and Business Angels |
|
Transaction Size: |
Non-disclosed |
|
Company Name: |
Ordrestyring.dk |
|
Closing: |
August 2018 |
|
Acquirer: |
Adelis Equity Partners |
|
TC Advisory: |
Translution Capital acted as financial advisor to the owners of Ordrestyring.dk in relation to a majority sale of the company to Adelis Equity Partners |
|
Transaction Size: |
Non-disclosed |
|
Company Name: |
Nordic Impact Funds |
|
Closing: |
June 2018 |
|
Investor: |
Institutional investors |
|
TC Advisory: |
Translution Capital acted as exclusive financial advisor to Nordic Impact Funds in the close of their first fund |
|
Transaction Size: |
DKK 35m |
|
Company Name: |
EuroInvestor |
|
Closing: |
March 2018 |
|
Investor: |
High Networth Individuals |
|
TC Advisory: |
Translution Capital acted as exclusive financial advisor to EuroInvestor in the fund-raising process led by several High Networth Individuals |
|
Transaction Size: |
Non-disclosed |
|
Company Name: |
Rødbillet.dk |
|
Closing: |
June 2017 |
|
Acquirer: |
Flixbus |
|
TC Advisory: |
Translution Capital acted as sole financial advisor to Rødbillet.dk in relation to the sale of 100% of the company to Flixbus, the German bus transportation company |
|
Transaction Size: |
SEK 35m |
|
Company Name: |
Saniona |
|
Closing: |
May 2017 |
|
Investor: |
Institutional investors |
|
TC Advisory: |
Translution Capital acted as joint bookrunner in the directed issue in Saniona on Nasdaq First North, led by Institutional investors |
|
Transaction Size: |
Non-disclosed |
|
Company Name: |
Shobr |
|
Closing: |
October 2016 |
|
Investor: |
A consortium of Danish Business Angels |
|
TC Advisory: |
Translution Capital acted as sole financial advisor to Shobr in relation to the capital raise led by a consortium of Danish Business Angels |